Wesley C. Van Voorhis

Wesley Van Voorhis practices at UW Medical Center - Montlake in Seattle, Washington, part of University of Washington.

Wesley Van Voorhis' NPI, 1851481717, was assigned on October 13, 2006. Wesley Van Voorhis graduated from JS Weill Medical College, Cornell University in 1984. Wesley Van Voorhis holds Washington license MD00023958.

Wesley Van Voorhis' primary practice is UW Medical Center - Montlake, at 1959 NE Pacific St Box 356151, Seattle, WA 98195 in King County. The practice phone is (206) 598-3300.

Wesley Van Voorhis' primary practice is UW Medical Center - Montlake in Seattle, Washington, part of University of Washington. The medical group on file is UW Physicians. Dmand AI also links Wesley Van Voorhis to 1 more hospital, 1 group practice or clinic and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Wesley Van Voorhis practices, 4 sites in all. Vendor and product names are available with a free account.

Infectious disease is Wesley Van Voorhis' primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Wesley Van Voorhis is licensed in Washington.

CMS data shows 99 Medicare services from Wesley Van Voorhis across 4 procedure codes in 2024, for 52 Medicare patients. Medicare paid $9,319 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 52 Medicare patients who saw Wesley Van Voorhis in 2024. The largest group is 65 to 74, with 24 patients. 73% of them have high blood pressure, and 67% have high cholesterol. Their average risk score is 2.23, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Wesley Van Voorhis' median patient age at 64, with 49% women.

In 2024, Wesley Van Voorhis wrote 170 Medicare Part D claims for 34 patients. 92% of them were for generic drugs. CMS names the drug for 70 of them, across 5 drugs with 11 or more claims each, at $2,518 in total drug cost. In 2023, CMS named 42 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Wesley Van Voorhis for performance year 2024, reported through an alternative payment model (APM). Wesley Van Voorhis accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Wesley Van Voorhis as offering telehealth.

CMS Open Payments shows 2 general payments to Wesley Van Voorhis from 2 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 59% of the total. Celgene Corporation paid the most, $37.

Wesley Van Voorhis graduated from JS Weill Medical College, Cornell University in 1984.